Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock

Figure 3

Network diagram of incidence of adverse reactions. Note: a, recombinant human brain natriuretic peptide; b, conventional treatment; c, dopamine; d, dobutamine; e, epinephrine; f, norepinephrine; g, milrinone; h, levosimendan.